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ABSTRACT  26 
A sensitive and selective method is needed to analyse in situ produced vitamin 27 
B12 in plant-based materials, potential new dietary sources of vitamin B12. A 28 
UHPLC/UV method was developed and validated for the determination of human 29 
active vitamin B12 in cell extracts of Propionibacterium freudenreichii subsp. 30 
shermanii and after immunoaffinity purification in extracts of cereal matrices 31 
fermented by P. freudenreichii. An Acquity HSS T3 C18 column resulted in a 32 
baseline separation, a calibration curve of excellent linearity and a low limit of 33 
detection (0.075 ng/5 µL injection). As confirmed by UHPLC-MS, the active 34 
vitamin B12 could be separated from pseudovitamin B12. The recovery of 35 
vitamin B12 from purified spiked cereal matrices was good (> 90%; RSD < 5%). 36 
A nutritionally relevant amount of active vitamin B12 was produced by P. 37 
freudenreichii in cereal malt matrices (up to 1.9 µg/100 g) in 24 h at 28 °C.  38 
 39 
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1. Introduction 51 
 52 
Vitamin B12, one of the water-soluble vitamins, is needed in humans and 53 
animals for the metabolic functions of two enzymes: methylmalonyl-CoA mutase 54 
and methionine synthase. According to Institute of Medicine (1998), the 55 
recommended dietary allowance (RDA) of vitamin B12 for adults is 2.4 µg/day. It 56 
is only synthesized by a few bacteria and archeae (Martens, Barg, Warren, & Jahn, 57 
2002). The structure of vitamin B12 consists of a corrin ring with a central cobalt 58 
atom complexed to four pyrrole rings, a lower α-ligand and an upper β-ligand. 59 
This vitamin includes three naturally occurring forms (adenosylcobalamin, 60 
methylcobalamin and hydroxycobalamin) and one chemically transformed form 61 
(cyanocobalamin), differing only in the upper ligand. Cyanocobalamin, the most 62 
stable form, is obtained by reacting natural vitamers with cyanide and it is the 63 
major vitamin B12 used in fortified foods, nutritional formula and pharmaceutical 64 
preparations (Ball, 2006). The lower ligand of vitamin B12 is 5,6-65 
dimethylbenzimidazole (DMBI), which is essential for the binding of the vitamin 66 
to the intrinsic factor for its absorption (Nielsen, Rasmussen, Andersen, Nexø, & 67 
Moestrup, 2012). Corrinoids with lower ligands other than DMBI are found in 68 
biological materials (Watanabe, Yabuta, Tanioka, & Bito, 2013). They are 69 
biologically inactive in humans but have vitamin activity in microorganisms 70 
(Herbert, 1988).  71 
Animal-based foods such as meat, fish, eggs and dairy products are the 72 
major contributors of vitamin B12 in the human diet. It is accumulated in animal 73 
tissues or milk, primarily as a result of the gut microbial activities and feed 74 
supplements. However, plant food materials are devoid of vitamin B12 (Ball, 75 
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2006; Herbert, 1988). A low level of vitamin B12 detected in some plant products 76 
and mushrooms probably originates from contaminating organisms or from 77 
vitamin uptake from soil residues (Koyyalamudi, Jeong, Cho, & Pang, 2009). 78 
Processed plant-based products (e.g. Tempe) have been found to contain a low 79 
level of vitamin B12 synthesized by the contaminating bacteria (Herbert, 1988; 80 
Keuth & Bisping, 1994; Mo et al., 2013). However, most of these data were 81 
obtained by a non-specific analytical method, i.e. microbiological assay (MBA), 82 
which does not differentiate between active forms of vitamin B12 and other 83 
corrinoids.  84 
The analysis of vitamin B12 in non-fortified foods is challenging due to its 85 
low concentration. The typical contents in animal-based foods milk, cheese, meat 86 
and liver have been reported to be 0.9, 2.4, 1‒2, and 83 µg/100 g, respectively 87 
(Ball, 2006). Natural forms of vitamin B12 are sensitive to light, therefore 88 
analytical methods utilise cyanide during the extraction to convert the natural 89 
forms into the more stable cyanocobalamin. Vitamin B12 in foods is traditionally 90 
determined by MBA using Lactobacillus delbrueckii ATCC 7830 as an assay 91 
organism, which is also the reference analytical method of AOAC (2006). 92 
Although it is a sensitive technique, MBA suffers from poor selectivity and often 93 
results in overestimation by 5‒30% since the test organism can react to 94 
compounds other than vitamin B12 forms, such as analogues and nucleic acids 95 
(Ball, 2006). One such inactive corrinoid for humans has been identified as 96 
pseudovitamin B12, which is produced by Lactobacillus reuteri CRL1098 (Santos 97 
et al., 2007). This corrinoid has adenine instead of DMBI as the lower ligand. In 98 
meat products, vitamin B12 contents were up to 2.2-fold higher with MBA 99 
compared with high performance liquid chromatography (HPLC; Guggisberg, 100 
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Risse, & Hadorn, 2012), reflecting the poor specificity of MBA. Moreover, MBA 101 
is labour intensive and time consuming. 102 
HPLC based methods have been developed for the determination of vitamin 103 
B12 in fortified foods, infant formula and vitamin supplements (Campos-Giménez, 104 
Fontannaz, Trisconi, Kilinc, Gimenez, & Andrieux, 2008; Chen, Wolf, 105 
Castanheira, & Sanches-Silva, 2010; Heudi, Kilinç, Fotannaz, & Marley, 2006; 106 
Marley, Mackay, & Young, 2009). Some studies have also focused on the 107 
quantification of vitamin B12 in non-fortified foods such as meat products 108 
(Guggisberg et al., 2012), and milk-based fermented products (Van Wyk & Britz, 109 
2010). These HPLC methods were based on UV detection. One HPLC method 110 
reported by Pakin, Bergaentzlé, Aoudé-Werner and Hasselmann (2005) used 111 
fluorescence detection after vitamin B12 was derivatised into a fluorescent 112 
compound, α-ribazole. The latter method was sensitive, but it required lengthy 113 
sample preparation time involving extensive sample derivatisation. The 114 
introduction of an immunoaffinity sample purification technique has improved the 115 
sensitivity of the HPLC measurement in fortified foods and supplements 116 
(Campos-Giménez et al., 2008; Heudi et al., 2006; Marley et al., 2009).  117 
However, the development of ultra-high performance liquid 118 
chromatographic (UHPLC) technology that uses separation column made up of 119 
sub-2 µm particles and improved instrumentation has considerably increased the 120 
sensitivity and resolution of the chromatographic analysis (Swartz, 2005).  To 121 
date, one method based on UHPLC with mass spectrometric (MS) detection has 122 
been reported for the analysis of vitamin B12 in milk and dairy products (Zironi, 123 
Gazzotti, Barbarossa, Devicienti, Scardilli, & Pagliuca, 2013). The enhanced 124 
sensitivity offered by the UHPLC technology and the sample clean-up and 125 
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concentrating potential of vitamin B12-specific commercial immunoaffinity 126 
columns have not yet been utilised for analysing vitamin B12 in natural or 127 
microbiologically processed foods. Particularly, it is necessary to confirm that the 128 
microbiologically synthesized forms are active for humans when biofortification 129 
is applied. Up to now, cereal matrices, which account for a major portion of the 130 
human diet but contain no vitamin B12, have not been considered for in situ 131 
enrichment with vitamin B12 using food-grade microorganisms.  132 
We are studying in situ production of vitamin B12 in cereal-based matrices 133 
using food-grade propionibacteria. Therefore, the aim of this study was to develop 134 
a sensitive UHPLC/UV method for the analysis of vitamin B12 in cells of 135 
Propionibacterium and in fermented cereal matrices. The new method was 136 
compared with MBA, and the need for immunoaffinity-based sample purification 137 
and confirmation of the structure of the synthesized vitamer by UHPLC-MS were 138 
explored. 139 
 140 
 141 
2. Materials and methods 142 
 143 
2.1. Chemicals, materials and reagents 144 
All chemicals and reagents used were of analytical grade. Sodium hydroxide, 145 
acetic acid and the vitamin B12 assay medium were obtained from Merck 146 
(Darmstadt, Germany); ethanol from Altia (Rajamäki, Finland); acetonitrile 147 
(HPLC grade), trifluoroacetic acid (TFA) and sodium cyanide from Sigma-148 
Aldrich (Steinheim, Germany); cyanocobalamin from Supelco (Bellefonte, USA); 149 
Tween 80 from Sigma (Aldrich, USA); and α-amylase (EC 232-588-1, A9857-150 
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5MU, Aspergillus oryzae) was from Sigma-Aldrich (Steinheim, Germany). A 151 
certified reference material BCR 487 (lyophilised pig liver; Institute for Reference 152 
Materials and Measurements, Geel, Belgium) was bought from Sigma-Aldrich. 153 
Water (later, MilliQ water) used for the preparation of reagents and analyses was 154 
obtained from a Milli-Q Plus system (0.22 µm, ≥ 18.2 MΩ cm, Millipore 155 
Corporation, Bedford, MA, USA). 156 
Cyanocobalamin stock solution (200 µg/mL) was prepared in 25% 157 
ethanol/MilliQ water and the concentration was measured by a spectrophotometer 158 
(Lambda 25 UV/Vis, Perkin Elmer Inc., USA) at 361 nm, as described by Indyk, 159 
Persson, Caselunghe, Moberg, Filonzi and Woollard (2002). 160 
 161 
2.2. Vitamin B12 extraction 162 
 163 
The protocol for vitamin B12 extraction (as cyanocobalamin) from sample 164 
matrices was adopted from Kelleher and Broin (1991) for plasma samples with 165 
some modifications. Cereal matrix (1–5 g), bacterial cell pellet (0.1–0.2 g) or pig 166 
liver (0.1 g) weighed in an extraction tube was vortexed with 10 mL buffer (8.3 167 
mM sodium hydroxide and 20.7 mM acetic acid; pH 4.5) containing 100 µL 1% 168 
sodium cyanide and placed in a boiling water bath for 30 min. The samples were 169 
then ice-cooled and centrifuged (Hermle, Wehingen, Germany) at 6900 × g for 10 170 
min. The supernatant was collected in a fresh tube. The residue pellet was 171 
vortexed once again with 5 mL buffer (pH 6.2, adjusted from the pH 4.5 buffer 172 
with 3% sodium hydroxide) and centrifuged. The supernatants were combined 173 
and the pH was adjusted to 6.2. The extract was then paper filtered (Ø 90 mm, 174 
VWR, Leuven, Belgium) and the volume was adjusted to 25 mL with pH 6.2 175 
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buffer. To ease the filtration of extracts for immunoaffinity purification, the 176 
cereal-based samples were treated with 1 mL of α-amylase solution (50 mg/mL) 177 
(37 °C; 30 min) to digest the starch before the boiling-water extraction (Marley et 178 
al., 2009). All the analytical processes were carried out under subdued light or 179 
were protected from direct light. The vitamin B12 content of the cereal matrices 180 
was expressed in terms of fresh weight (ng/g matrix) and that of cells per unit 181 
volume fermented medium (ng/mL). 182 
 183 
2.3. Immunoaffinity purification for UHPLC quantification 184 
 185 
The sample clean-up in the immunoaffinity column “Easy-Extract®” (R-186 
Biopharma, Glasgow, Scotland) was carried out according to the manufacturer’s 187 
instructions. Briefly, the buffer in the immunoaffinity column was drained, after 188 
which 10‒15 mL of the filtered (0.45 µm, Pall, Cornwall, UK) sample extract 189 
was loaded into the column. The column was washed with 10 mL of MilliQ water 190 
and 50 mL of air was applied. Vitamin B12 was then eluted with 3 mL of 191 
methanol and the elution was completed with an additional 0.5 mL of methanol. 192 
The eluate was evaporated at 50 °C under a stream of nitrogen and the residue 193 
was reconstituted in 300 µL of MilliQ water, which was then syringe filtered (0.2 194 
µm, Pall, Cornwall, UK) to a Waters total recovery UPLC vial.  195 
 196 
2.4. Ultra-high performance liquid chromatography (UHPLC) 197 
 198 
2.4.1. UHPLC system 199 
 200 
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The chromatographic analysis was performed on a Waters Acquity UPLC 201 
system (Milford, MA, USA) equipped with a photodiode array detector (PDA; 202 
210–600 nm). In addition, it consisted of a binary solvent manager, autosampler 203 
and column manager. The detection was performed at 361 nm and the absorption 204 
spectra were recorded by the PDA. The autosampler was maintained at 4 °C and 205 
the column was operated at 30 °C. The autosampler injected the sample solutions 206 
(2–15 µL) onto a column via a 20-µL injection loop operated in a partial-loop 207 
mode. Chromatographic data were collected and processed using the Waters 208 
Empower 2 software.    209 
 210 
2.4.2. Method optimisation and validation 211 
 212 
Two reversed-phase C18 columns, high-strength silica T3 (HSS) and 213 
ethylene bridged hybrid (BEH) from Waters (Milford, MA, USA), of similar 214 
dimensions (2.1 x 100 mm; 1.8 µm and 1.7 µm particles, respectively) were 215 
evaluated for the separation of vitamin B12 from sample extracts. A set of flow 216 
rates (0.32‒0.50 mL/min) was tested in a linear gradient mode of the mobile 217 
phase consisting of MilliQ water (solvent A) and acetonitrile (solvent B); each 218 
modified with 0.025% TFA. Finally, the following mobile phase gradients 219 
(solvent A: solvent B) were maintained during a 10-min run: 0–0.5 min (95:5); 220 
0.5–5 min (60:40); 5–6 min (60:40); and 6–10 min a linear gradient from 60:40 to 221 
95:5 for equilibration. A calibration curve was produced in each sample set from 222 
six cyanocobalamin standards with the vitamin concentration ranging from 223 
0.015‒0.75 ng/µL; each standard solution was injected twice. The 224 
chromatographic method was assessed for the linearity of the calibration curve, 225 
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limit of detection (LOD: signal-to-noise ratio, S/N= 3), and limit of quantitation 226 
(LOQ: 3 times the LOD) of vitamin B12 using the cyanocobalamin standard 227 
solutions. The resolution (calculated according to the formulae in the US 228 
Pharmacopeia; USP) for the separation of cyanocobalamin in sample extracts and 229 
the number of theoretical plates (USP) for each column were compared. LOD, 230 
resolution and number of theoretical plates were obtained with the Waters 231 
Empower 2 software. 232 
 233 
2.5. UHPLC-MS/MS analysis 234 
 235 
The mobile phase was modified with 0.5% formic acid instead of 0.025% 236 
TFA for the UHPLC-MS study to minimise the ion suppression. The MS analysis 237 
was carried out in a positive ion mode on an Esquire-LC quadrupole ion trap mass 238 
spectrometer with an electrospray ionization (ESI) interface (Bruker Daltonics, 239 
Bremen, Germany) and the data were analysed by the LC-MSD Trap version 5.2 240 
(Bruker Daltonics). The scanning was carried out for a range of m/z 900‒1400 241 
and the tandem mass spectrometry (MS/MS) was performed for a particular m/z 242 
according to the target molecule(s) using helium as the collision gas. The 243 
following instrumental settings optimised for cyanocobalamin were used for the 244 
MS analysis of cyanocobalamin ([M+H]+ m/z 1356) and pseudovitamin B12 245 
([M+H]+ m/z 1345) in sample extracts: nebulizer (nitrogen) 50.0 psi, dry gas 246 
(nitrogen) 8.0 L/min, dry temperature 300 °C, capillary 4500 V, end plate offset 247 
−250 V and trap drive 84. 248 
 249 
2.6. Microbiological assay  250 
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 251 
The MBA was performed on a 96–well microtiter plate (Corning, NY, USA) 252 
based on Kelleher and Broin (1991) using L. delbrueckii ATCC 7830 as an assay 253 
organism and cyanocobalamin as a calibrant. The sample extracts were 254 
appropriately diluted at two levels with the extraction buffer (pH 6.2). A certified 255 
reference material BCR 487 (pig liver) extract served as a reference sample in 256 
each set of samples. A blank extract was used to obtain the actual readings of the 257 
samples. Cyanocobalamin solutions of increasing concentration (0–8 pg/well) and 258 
sample extracts, both 100 µL, were inoculated into the wells of the microtiter plate 259 
(4 wells for each concentration), and 200 µL of freshly prepared sterile filtered 260 
vitamin B12 assay medium (pH 6.2) inoculated with the cryopreserved assay 261 
organism was introduced into each well. The plate was then incubated at an 262 
optimised condition (35 °C; 19 h) and the turbidity was measured with a micro-263 
plate reader (Multiskan EX; Labsystems, Finland) at 595 nm. A calibration curve 264 
of 8 concentration levels and the amount of vitamin B12 in each well were 265 
obtained automatically by Ascent software version 2.6 (Labsystems).  266 
 267 
2.7. Recovery study 268 
 269 
Since natural cereal matrices do not contain vitamin B12, the unfermented 270 
rye malt matrix (from Section 2.8.) was used as a blank matrix for the recovery 271 
study. The sample matrix (1.5 g) was spiked with cyanocobalamin at two levels 272 
(17.7 ng and 53.1 ng), each level in triplicate, and vitamin B12 was extracted and 273 
analysed by MBA directly and by UHPLC after immunoaffinity purification, as 274 
explained earlier. The repeatability was shown by carrying out two independent 275 
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experiments on two days. To test the effect of the sample matrix, the recovery was 276 
also studied in the extraction buffer with the lower level of spiking (17.7 ng). The 277 
recovery was calculated from the measured cyanocobalamin concentration in the 278 
spiked samples to the concentration of added cyanocobalamin in the samples. 279 
 280 
2.8. Bacterial culture and fermentation of sample matrices  281 
 282 
Propionibacteria capable of vitamin B12 synthesis and allowed for use in 283 
food production are mostly used in cheese manufacturing and in the industrial 284 
production of vitamin B12 with genetically engineered strains (Thierry, Deutsch, 285 
Falentin, Dalmasso, Cousin, & Jan, 2011). For this study, a strain of 286 
Propionibacterium freudenreichii subsp. shermanii (P. freudenreichii ABM 5378) 287 
isolated from a cheese starter culture was used for the production of vitamin B12 288 
in the sample matrices.  289 
Malt matrices: The fermented cereal samples were produced to study the 290 
suitability of the developed method; the fermentation conditions used were not 291 
optimised for vitamin B12 production. Rye and barley malt flours obtained by 292 
milling malted grains (Laihian Mallas, Laihia, Finland) were separately mixed in 293 
boiling MilliQ water (33% w/v) and cooked for 2 min. The gelatinised matrices 294 
were transferred to glass flasks and then autoclaved at 121 °C for 15 min. The 295 
culture preparation and fermentation of the matrices were carried out as described 296 
by Kariluoto et al. (2010). Briefly, the cooled matrices were aseptically 297 
transferred into pre-sterilised flasks and a culture of P. freudenreichii ABM 5378 298 
was inoculated. The matrices were allowed to ferment at 28 °C for 24 h. After the 299 
incubation, the cell counts (CFU/g) had increased by a log factor in both matrices 300 
  
13 
 
while pH had decreased from 5.6 to 5.3 in the rye matrix and 5.4 to 5.2 in the 301 
barley matrix. Likewise, an aqueous barley malt extract was fermented with 302 
unidentified strains of bacteria producing lactic and propionic acids and then 303 
concentrated. 304 
Supplemented whey permeate (SWP): P. freudenreichii ABM 5378 was 305 
grown in the SWP medium anaerobically for 72 h and then aerobically for 96 h at 306 
30 °C (Hugenschmidt, Schwenninger, Gnehm, & Lacroix, 2010). Cheese whey 307 
powder (Valio, Espoo, Finland) was used instead of whey permeate powder, as in 308 
the study of Hugenschmidt et al. (2010), and the medium was supplemented with 309 
5 mg/L cobalt(II) chloride (Sigma-Aldrich). The fermented broth was centrifuged 310 
( 12000 × g;10 min), the resulting cell pellet was re-suspended in 10 mL of pH 7.3 311 
PBS buffer (Oxoid, Hampshire, England) and centrifuged again. The fresh cell 312 
mass obtained was stored at −20 °C until the analysis. 313 
2.9. Statistical analysis 314 
All the statistical analyses were performed using IBM SPSS 20.0 (IBM 315 
Corporation, NY, USA). Average, standard deviation (SD) and relative standard 316 
deviation (RSD) are reported. One-way analysis of variance (ANOVA) and Tukey 317 
post hoc test were performed to compare between respective UHPLC and MBA 318 
results. A p value of < 0.05 was considered statistically significant different. 319 
 320 
3. Results and Discussion 321 
 322 
3. 1. UHPLC method optimisation and validation 323 
 324 
  
14 
 
Gradient elution of the mobile phase consisting of water and acetonitrile 325 
modified with 0.025% TFA at a flow rate of 0.32 mL/min was found to be 326 
optimal for vitamin B12 separation on both the HSS T3 and BEH column. A 327 
higher flow rate (0.47 mL/min) resulted in a co-elution of interfering compounds 328 
in the sample extracts. Owen, Lee, and Grissom (2011) used the same flow rate 329 
and the mobile phase gradient for the separation of physiologic cobalamins from 330 
samples of cell culture media by a BEH C18 column.. A sharper cyanocobalamin 331 
peak was produced by the HSS column than that by the BEH column both for the 332 
standard solution and for the sample extracts (Figure 1). The height of the 333 
cyanocobalamin peak for an equal volume of the injected sample was about 1.4-334 
fold on the HSS column compared to that on the BEH column. The number of 335 
theoretical plates of the HSS column was greater by a factor of 2.5, as evidenced 336 
by a narrower and a sharper peak on the HSS column. Furthermore, a higher USP 337 
peak resolution (1.80) was obtained with the HSS column than with the BEH 338 
column (1.10) under identical elution conditions (Fig. 1). In addition, co-elution 339 
of an interfering compound was observed for the extracts of P. freudenreichii 340 
cells leading to the tailing of the peak on the BEH column, whereas the 341 
cyanocobalamin peak was well separated on the HSS column. Therefore, the HSS 342 
T3 C18 column was chosen for the validation and the analysis of vitamin B12 in 343 
sample matrices.  344 
 345 
Fig. 1 346 
 347 
The retention time of cyanocobalamin was stable during the analyses, 348 
irrespective of the sample matrices. The 30-day average retention time was 3.27 349 
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min with a narrow change from 3.25 to 3.29 min over the study period. The 350 
UHPLC analysis was faster with a total run time of 10 min compared with over 30 351 
min that was required for the HPLC methods (Heudi et al., 2006; Marley et al., 352 
2009). An external calibration curve of excellent linearity (R2 > 0.999) was 353 
achieved by injecting a series of cyanocobalamin standard solutions (0.015‒0.75 354 
ng/µL). The instrumental LOD and LOQ were 0.075 ng/inj and 0.225 ng/inj, 355 
respectively, for a 5 µL injection. Previous HPLC/UV methods resulted in higher 356 
LODs at the larger injection volumes: 1.5 ng/inj (50–100 µL) (Guggisberg et al., 357 
2012; Marley et al., 2009) and 3–3.3 ng/inj (100 µL) (Chen et al., 2010; Heudi et 358 
al., 2006). The enhanced sensitivity allowed for the analysis with small samples 359 
(< 5 g), unlike the bulk quantity needed for HPLC analysis (Campos-Giménez et 360 
al., 2008; Guggisberg et al., 2012); thus minimising the matrix-related 361 
interference. Moreover, HPLC methods have mostly been developed for fortified 362 
foods and supplements for measuring added cyanocobalamin, at levels greater 363 
than those normally found in foods. 364 
 365 
Table 1 366 
 367 
The accuracy of the UHPLC method was studied by determining the 368 
recovery of spiked cyanocobalamin from a rye malt matrix. Low levels were 369 
chosen to cover concentrations that are possible in the fermented cereal matrices. 370 
The added levels were still too low to be detected with UHPLC without 371 
purification of the extracts. On the other hand, the usefulness of the additional 372 
purification and enrichment on the immunoaffinity columns was demonstrated by 373 
the good recoveries at both levels. The mean inter-day recovery of 374 
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cyanocobalamin by UHPLC/UV was about 95% with a relative standard deviation 375 
(RSD) of < 5.0%, for both levels (Table 1). The cereal matrix did not affect the 376 
recovery of the cyanocobalamin, as evident from a similar recovery obtained in 377 
the extraction buffer. Equivalent recoveries of spiked concentrations were also 378 
obtained by the MBA (p > 0.05; Table 1). Recently, the HPLC determination of 379 
vitamin B12 in complex fortified foods was improved with the application of an 380 
immunoaffinity sample purification and enrichment column (Heudi et al., 2006), 381 
and then successfully validated in further studies (Campos-Giménez et al., 2008; 382 
Marley et al., 2009). In these earlier studies, a good recovery was also obtained 383 
for cyanocobalamin; however, much higher spiking concentrations were used. 384 
Interestingly, Marley et al. (2009) found that the affinity of other vitamin B12 385 
forms to antibodies was lower; e.g. hydroxycobalamin was recovered only up to 386 
75%, suggesting the benefit of converting natural forms into cyanocobalamin for 387 
the accurate determination of vitamin B12.   388 
For BCR 487, a vitamin B12 content of 876 ng/g of dm (dry matter) was 389 
obtained by the UHPLC analysis, whereas the MBA resulted in a higher 390 
concentration (1056±80 ng/g of dm) (Table 2). The latter was in agreement with 391 
the certified reference value (1120±90 ng/g of dm). The UHPLC determined 392 
content was 83% of the MBA result (p < 0.05; Table 2); the difference could be 393 
due to the non-specificity of MBA. The certified vitamin B12 value of BCR 487 394 
is based on the data obtained with the MBA. To our knowledge, this is the first 395 
report of the chromatographically analysed vitamin B12 content of BCR 487. A 396 
locally lyophilised pig liver sample analysed with HPLC after immunoaffinity 397 
purification had a vitamin B12 content of only 597‒656 ng/g (Guggisberg et al., 398 
2012). Distribution of corrinoids in pig liver has not been studied in detail. 399 
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However, Kelly, Gruner, Furlong and Sykes (2006) investigated corrinoids in 400 
lamb tissues, including the liver, by HPLC. Contrary to previous reports that 401 
corrinoids in the lamb liver were exclusively vitamin B12, these authors found 402 
quite a marked fraction of the total corrinoids (up to 30%) as vitamin B12 403 
analogues.  404 
 405 
Table 2 406 
 407 
3.2. UHPLC analysis of vitamin B12 in cells and fermented cereal matrices 408 
 409 
Figure 2 shows example chromatograms with and without the 410 
immunoaffinity clean-up for extracts of cells, pig liver, spiked rye malt matrix and 411 
fermented rye malt matrix. Without the immunoaffinity purification, a higher 412 
chromatographic background was obtained for the pig liver and the fermented 413 
malt matrices while a cleaner chromatogram with a well-separated 414 
cyanocobalamin peak (retaining at 3.27 min) was observed for the cell extract. 415 
Besides the matrix effect on separation, another disadvantage was that the 416 
concentration of cyanocobalamin in these extracts was low or below the LOD 417 
(0.075 ng/5 µL injection). The immunoaffinity purified extracts produced a well-418 
separated peak with none or little background interference, demonstrating the 419 
usefulness of the immunoaffinity clean-up for the analysis of low levels of 420 
vitamin B12 in the complex matrices. Guggisberg et al. (2012) reported its 421 
applicability for the analysis of vitamin B12 in meat and meat products. 422 
Nevertheless, analysis of the matrices such as microbial cells, containing a higher 423 
level of vitamin B12, did not require the immunoaffinity purification. Therefore, 424 
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especially with the immunoaffinity purification this method could also be 425 
applicable for other matrices. Separate validation for each material however is 426 
needed. 427 
Fig. 2 428 
 429 
The corrinoid in the cell extract, the immunoaffinity purified fermented malt 430 
matrices and the pig liver eluted at the retention time of the cyanocobalamin 431 
standard (Fig. 2) and had a PDA spectrum (210‒600 nm) identical to that of 432 
cyanocobalamin (Fig. 3). Furthermore, the UHPLC-MS/MS analysis revealed that 433 
the fragmentation profile of the corrinoid for the m/z of 1356, [M+H]+ of 434 
cyanocobalamin, was similar to that of the cyanocobalamin standard, as shown in 435 
the example mass spectra (Figs. 4A; 4B). The following major fragmentation 436 
products of cyanocobalamin, as explained by Carkeet et al. (2006) and shown in 437 
Figure 4A, were observed: m/z 1210 [M+H−DMBI]+; m/z 1124 438 
[M+H−DMBI−CN−Co]+; m/z 997 [M+H−DMBI−sugar−PO3]+ and m/z 912 439 
[M+H−DMBI−sugar−PO3−CN−Co]+. These observations confirmed that the 440 
lower ligand of the corrinoid in the sample extracts was DMBI as in 441 
cyanocobalamin, which is critical for the binding of the B12 vitamer to the 442 
intrinsic factor to make it bioavailable for humans (Nielsen, Rasmussen, Andersen, 443 
Nexø, & Moestrup, 2012).  444 
 445 
Fig. 3 446 
 447 
Fig. 4 448 
 449 
  
19 
 
The UHPLC analysis of P. freudenreichii cells obtained from the fermented 450 
SWP accounted for a vitamin B12 production of 620 ng/mL. In a study by 451 
Hugenschmidt et al. (2010), 37 screened P. freudenreichii strains produced 452 
vitamin B12 of approximately 100 to 2500 ng/mL in SWP with added cobalt and 453 
DMBI, showing an inter-strain diversity of vitamin B12 synthesis. In our study, 454 
the medium was not supplemented with DMBI. Thus, DMBI had to be 455 
synthesized by the bacteria from the substrate in the SWP, which might have 456 
limited the vitamin B12 production.   457 
To the best of our knowledge, we are the first to report vitamin B12 in situ 458 
production in cereal matrices with propionibacteria and its analysis by UHPLC. 459 
The vitamin B12 content of the P. freudenreichii fermented rye and barley malt 460 
matrices measured with the UHPLC was 19.3 ng/g and 15.7 ng/g of fresh weight, 461 
respectively (Table 2). On the other hand, the UHPLC analysis of the fermented 462 
malt extract after the immunoaffinity purification revealed a peak in the 463 
chromatogram at 3.22 min (Fig. 3A), i.e., before the retention time of 464 
cyanocobalamin (3.27 min) from the standard solution and the immunoaffinity 465 
purified pig liver extract (Figs. 3B; 3C). Its PDA spectrum (210‒600 nm) was, 466 
however, similar to that of cyanocobalamin. This peak, which was not seen in the 467 
chromatograms of any other analysed samples, was suggested to be of 468 
pseudovitamin B12 with adenine as its lower ligand. It is a corrinoid known to be 469 
present in biological materials (Watanabe et al., 2013) and has been recently 470 
characterised in L. reuteri CRL1098 (Santos et al., 2007). When the sample 471 
extract was analysed by MS/MS for an m/z of 1356, [M+H]+ of cyanocobalamin, 472 
no fragment ions characteristic of cyanocobalamin were observed. However, a 473 
fragmentation profile identical to the cyanocobalamin standard was obtained by 474 
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the MS/MS for an m/z of 1345, [M+H]+ of pseudovitamin B12 (Fig. 4C: m/z 1210 475 
[M+H−adenine]+; m/z 1124 [M+H−adenine−CN−Co]+; m/z 997 476 
[M+H−adenine−sugar−PO3]+ and m/z 912 [M+H−adenine−sugar−PO3−CN−Co]+. 477 
The similar fragment ions obtained for the m/z of 1345 with that for the m/z of 478 
1356 confirmed that the molecule had a structure otherwise similar to 479 
cyanocobalamin, but a different lower ligand: adenine in place of DMBI.  480 
 481 
3.3. Comparison between UHPLC analysis and MBA 482 
 483 
The MBA results of the P. freudenreichii cells were similar to the UHPLC 484 
derived results, whereas analysis of the certified reference pig liver (BCR 487) 485 
resulted in a 17% higher vitamin B12 content by the MBA (Table 2). The vitamin 486 
B12 contents determined by the UHPLC were 67% and 63% of the MBA results 487 
for the fermented rye and barley matrices, respectively (Table 2). For the malt 488 
extract fermented with bacteria producing lactic and propionic acids no detectable 489 
level of cyanocobalamin was found by the UHPLC method in contrast to 1200 490 
ng/g of vitamin B12 measured by the MBA. These sample-specific differences of 491 
the vitamin B12 contents when measured by the MBA or UHPLC method could 492 
be due to the inherent drawbacks associated with the MBA.  493 
The MBA has been the golden standard method allowing for the 494 
determination of low levels of vitamin B12 in foods and biological materials. 495 
However, it has been reported to give higher vitamin B12 results than HPLC in 496 
biological and fermented materials. The higher results are possible, as the assay 497 
organism also responds to corrinoids that are inactive for humans, e.g. 498 
pseudovitamin B12 and nucleic acids (Ball, 2006; Herbert, 1988; Indyk et al., 499 
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2002). These inactive corrinoids were reported in ovine tissues (Kelly et al., 2006) 500 
and may also be synthesized by microorganisms (Herbert, 1988), including 501 
propionibacteria. Quesada-Chanto et al. (1998) analysed vitamin B12 in the cells 502 
of three strains of propionibacteria by an HPLC method and two 503 
spectrophotometric methods. Vitamin B12 was only detected in cells of P. 504 
freudenreichii with HPLC, whereas vitamin B12 analogues with retention time 505 
different than authentic vitamin B12 were observed in the cells of other two 506 
strains. However, one strain produced authentic vitamin B12 when the culture 507 
medium was supplemented with DMBI. On the other hand, some bacteria produce 508 
only inactive corrinoids even in the presence of DMBI. L. reuteri CRL1098 509 
produced pseudovitamin B12 exclusively in a growth medium supplemented with 510 
and without DMBI under anaerobic conditions (Santos et al., 2007).  511 
Campos-Giménez et al. (2008) noticed a 20–30% higher vitamin B12 512 
content in milk-based infant cereals and soy-based fortified formula by MBA 513 
compared to HPLC. Poor selectivity of the MBA was further shown in the 514 
analysis of spirulina tablets and shellfish where the MBA results were up to 6–8-515 
fold higher than concentrations determined by a specific intrinsic factor based 516 
chemiluminescence method (Watanabe, Takenaka, Abe, Tamura, & Nakano, 517 
1998). The majority of the measured vitamin B12 may thus have been inactive 518 
corrinoids.  519 
 520 
4. Conclusion 521 
 522 
The developed UHPLC/UV method enabled sensitive and specific 523 
quantitation of the vitamin B12 content in microbial cells, and in fermented cereal 524 
  
22 
 
matrices after purification on immunoaffinity columns. This method allowed for 525 
the selective determination of bioactive vitamin B12, thus eliminating the 526 
possibility of measuring inactive corrinoids as in the MBA. One such analogue, 527 
pseudovitamin B12, was identified and confirmed in a malt extract fermented by 528 
bacteria producing lactic and propionic acids. A nutritionally relevant amount of 529 
active vitamin B12 was produced by P. freudenreichii in rye and barley malt 530 
matrices. The LC-MS is a useful tool for the identification of in situ produced 531 
bioactive vitamin B12 from inactive corrinoids in food matrices or microbial 532 
materials.  533 
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Figure captions: 650 
 651 
Fig. 1. Chromatograms showing the separation characteristics of the HSS T3 and 652 
BEH C18 columns (2.1 mm x 100 mm, 1.8 and 1.7 µm particles) for 653 
cyanocobalamin from standard solution (0.15 ng/µL), an immunoaffinity purified 654 
extract of BCR 487 (lyophilised pig liver) and an extract of P. freudenreichii 655 
cells. The injection volume, flow rate, column temperature and mobile phase were 656 
identical. 1 = cyanocobalamin peak on HSS column, 2 = cyanocobalamin peak on 657 
BEH column. 658 
 659 
Fig. 2. Chromatograms of unpurified and immunoaffinity purified extracts of 660 
BCR 487 pig liver, cyanocobalamin-spiked control rye malt matrix, fermented rye 661 
malt matrix and cells of P. freudenreichii. The cyanocobalamin concentration 662 
(ng/µL) of the purified extract of pig liver, spiked matrix, fermented rye malt 663 
matrix and cells were 0.166, 0.034, 0.037, and 0.180, respectively. The injection 664 
volume was 10 µL. 1 = cyanocobalamin peak (retention time: 3.27 min). 665 
 666 
Fig. 3. Chromatograms of immunoaffinity purified extracts of malt extract 667 
fermented with bacteria producing lactic and propionic acids (A), P. 668 
freudenreichii fermented rye malt matrix (B) and cyanocobalamin standard 669 
solution (C). tR = retention time.  670 
 671 
Fig. 4. UHPLC-MS/MS spectra of an m/z [M+H]+ of 1356 for the 672 
cyanocobalamin standard (A) and the corrinoid in the immunoaffinity purified 673 
extract of the fermented barley malt matrix (B), and of an m/z [M+H]+ of 1345 674 
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(pseudovitamin B12) for immunoaffinity purified malt extract fermented with 675 
bacteria producing lactic and propionic acids (C). 676 
 677 
 678 
Table captions:  679 
 680 
Table 1. Recovery of cyanocobalamin by UHPLC/UV from immunoaffinity 681 
purified extracts of the spiked unfermented rye malt matrix (1.5 g) and the 682 
microbiological assay (MBA) of the extracts without purification  (n = 3; for both 683 
days). 684 
 685 
Table 2. Vitamin B12 contents of certified reference material BCR 487 686 
(lyophilised pig liver), P. freudenreichii fermented cereal matrices (28 °C; 24 h), 687 
cell mass from P. freudenreichii fermented supplemented whey permeate (SWP) 688 
(30 °C; 168 h) and concentrated malt extract fermented with bacteria producing 689 
lactic and propionic acids determined by UHPLC and MBA.   690 
  
 
 
ND = Not detected 
NA =
 
Not analysed 
Values with dissimilar superscript letters (a and b) along each row indicate significant difference (p 
< 0.05). 
 
Sample 
Spiked amount 
(ng) 
Recovery, % (RSD, %) 
  Day 1 Day 2 
  UHPLC MBA UHPLC MBA 
 0.0 ND ND ND ND 
Rye malt matrix 17.7 97.2 (3.1)
a
 95.0 (0.9)
a
 93.8 (5.3)
a
 98.2 (4.3)
a
 
 53.1 96.8 (2.4)
a
 94.8 (3.7)
a
 91.2 (2.5)
a
 96.1 (5.7)
a
 
Extraction Buffer 17.7 94.6 (1.0)
a
 92.7 (5.7)
a
 97.4 (1.9) NA 
 
 
 
     
  
 
Sample 
UHPLC 
(ng/g) 
MBA  
(ng/g) 
UHPLC/MBA, 
% 
BCR 487 pig liver (n = 8) 876 (±49)
a* 1056 (±80)b* 82.9 
Fermented rye malt matrix (n = 2 × 2)
‡
 19.3 (±1.5)
a
 28.8 (±2.4)
b
 67.0 
Fermented barley malt matrix (n = 2 × 2)
‡
 15.7 (±2.4)
a
 25.0 (±2.3)
b
 62.8 
 
Cell mass (from fermented SWP) 
 (n = 3) 
 
620 (±90)
a#
 
(ng/mL) 
 
650 (±60)
a#
 
(ng/mL) 
95.4 
    
Concentrated fermented malt extract  
(n = 3) 
ND 1196 ± 56 - 
 
    
 
Values are means ± SD 
Values with different superscript letters (a and b) along the row indicate significant difference (p < 0.05)
 
*Dry matter basis 
‡
Biological replicates = 2 and analytical replicates = 2 
#
Expressed per unit volume fermented medium 
 ND = Not detected 
SWP = supplemented whey permeate 
The certified value for BCR 487 was 1120±90 ng/g of dry matter. 
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 A sensitive UHPLC/UV method was developed for the analysis of vitamin 
B12. 
 The method was suitable for analysing microbial cells and fermented 
cereal matrices. 
 Immunoaffinity purification enabled analysis of vitamin B12 in fermented 
cereal matrices. 
 Active vitamin B12 was produced in cells and cereal matrices by P. 
freudenreichii. 
 Pseudovitamin B12 could be separated and further identified with 
UHPLC-MS. 
